{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T23:52:24Z","timestamp":1789948344040,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.atherosclerosis.2015.08.011","type":"journal-article","created":{"date-parts":[[2015,8,8]],"date-time":"2015-08-08T16:21:17Z","timestamp":1439050877000},"page":"469-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques"],"prefix":"10.1016","volume":"242","author":[{"given":"I.M.","family":"Quesada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lucero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Amaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.N.","family":"Meijles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Cifuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.011_bib1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.coph.2013.01.003","article-title":"Inflammation and atherosclerosis: direct versus indirect mechanisms","volume":"13","author":"Rosenfeld","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"20","key":"10.1016\/j.atherosclerosis.2015.08.011_bib2","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1007\/s00018-013-1289-1","article-title":"Inflammation and immune system interactions in atherosclerosis","volume":"70","author":"Legein","year":"2013","journal-title":"Cell Mol. Life Sci."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2015.08.011_bib3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5551\/jat.E489","article-title":"Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery","volume":"14","author":"Watanabe","year":"2007","journal-title":"J.\u00a0Atheroscler. Thromb."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2015.08.011_bib4","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI19628","article-title":"Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice","volume":"113","author":"Hu","year":"2004","journal-title":"J.\u00a0Clin. Invest."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.011_bib5","doi-asserted-by":"crossref","first-page":"H295","DOI":"10.1152\/ajpheart.00884.2009","article-title":"The vasa vasorum in diseased and nondiseased arteries","volume":"298","author":"Mulligan-Kehoe","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"21","key":"10.1016\/j.atherosclerosis.2015.08.011_bib6","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2007.01.089","article-title":"Plaque neovascularization and antiangiogenic therapy for atherosclerosis","volume":"49","author":"Doyle","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.08.011_bib7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cardiores.2007.06.020","article-title":"The dynamic vasa vasorum","volume":"75","author":"Ritman","year":"2007","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.011_bib8","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.ijcard.2013.01.278","article-title":"Mechanisms of oxidative stress in human aortic aneurysms \u2013 Association with clinical risk factors for atherosclerosis and disease severity","volume":"168","author":"Guzik","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2015.08.011_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.freeradbiomed.2013.06.025","article-title":"Oxidative Stress in atherosclerosis: The Role of microRNAs in Arterial Remodelling","volume":"64","author":"Zampetaki","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.011_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2217\/14796678.5.1.83","article-title":"Role of NADPH oxidase in atherosclerosis","volume":"5","author":"Violi","year":"2009","journal-title":"Future Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2015.08.011_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2217\/bmm.10.57","article-title":"Biomarkers of inflammation and oxidative stress in atherosclerosis","volume":"4","author":"Uno","year":"2010","journal-title":"Biomark. Med."},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2015.08.011_bib12","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1582-4934.2009.00978.x","article-title":"The vicious circle between oxidative stress and inflammation in atherosclerosis","volume":"14","author":"Hulsmans","year":"2010","journal-title":"J.\u00a0Cell. Mol. Med."},{"issue":"2\u20133","key":"10.1016\/j.atherosclerosis.2015.08.011_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejphar.2011.02.022","article-title":"Antioxidant and signal modulation properties of plant polyphenols in controlling vascular inflammation","volume":"658","author":"Kostyuk","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.011_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/CIRCIMAGING.112.975193","article-title":"Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition","volume":"6","author":"Liu","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2015.08.011_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1172\/JCI200111927","article-title":"p47phox is required for atherosclerotic lesion progression in ApoE(\u2212\/\u2212) mice","volume":"108","author":"Barry-Lane","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.08.011_bib16","first-page":"401","article-title":"Current status of NADPH oxidase research in cardiovascular pharmacology","volume":"9","author":"Rodino-Janeiro","year":"2013","journal-title":"Vasc. Health Risk Manag."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2015.08.011_bib17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.freeradbiomed.2011.04.025","article-title":"Nox2 B-loop peptide, Nox2ds, specifically inhibits the NADPH oxidase Nox2","volume":"51","author":"Csanyi","year":"2011","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.08.011_bib18","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/hh1701.096037","article-title":"Novel competitive inhibitor of NAD(P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice","volume":"89","author":"Rey","year":"2001","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2015.08.011_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.RES.0000063423.94645.8A","article-title":"Novel NAD(P)H oxidase inhibitor suppresses angioplasty-induced superoxide and neointimal hyperplasia of rat carotid artery","volume":"92","author":"Jacobson","year":"2003","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.08.011_bib20","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/01.ATV.0000066684.37829.16","article-title":"NAD(P)H oxidase mediates angiotensin II-induced vascular macrophage infiltration and medial hypertrophy","volume":"23","author":"Liu","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2015.08.011_bib21","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/01.RES.0000020404.01971.2F","article-title":"Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II","volume":"90","author":"Touyz","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2015.08.011_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/978-1-59745-467-4_25","article-title":"Cell-free assays: the reductionist approach to the study of NADPH oxidase assembly, or \u201call you wanted to know about cell-free assays but did not dare to ask\u201d","volume":"412","author":"Molshanski-Mor","year":"2007","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.08.011_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3109\/10715762.2014.889295","article-title":"Tempol attenuates atherosclerosis associated with metabolic syndrome via decreased vascular inflammation and NADPH-2 oxidase expression","volume":"48","author":"Cannizzo","year":"2014","journal-title":"Free Radic. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.011_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2144\/05381RV01","article-title":"Zymographic techniques for the analysis of matrix metalloproteinases and their inhibitors","volume":"38","author":"Snoek-van Beurden","year":"2005","journal-title":"BioTechniques"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.011_bib25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/cvr\/cvm111","article-title":"Visfatin induces human endothelial VEGF and MMP-2\/9 production via MAPK and PI3K\/Akt signalling pathways: novel insights into visfatin-induced angiogenesis","volume":"78","author":"Adya","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.011_bib26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/ATVBAHA.112.300438","article-title":"Reduced atherosclerotic burden in subjects with genetically determined low oxidative stress","volume":"33","author":"Violi","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"16","key":"10.1016\/j.atherosclerosis.2015.08.011_bib27","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/CIRCULATIONAHA.109.877191","article-title":"Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter study","volume":"120","author":"Violi","year":"2009","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2015.08.011_bib28","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1089\/ars.2012.4987","article-title":"Does NADPH oxidase deficiency cause artery dilatation in humans?","volume":"18","author":"Loffredo","year":"2013","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.atherosclerosis.2015.08.011_bib29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.redox.2014.04.004","article-title":"Nox4 NADPH oxidase contributes to smooth muscle cell phenotypes associated with unstable atherosclerotic plaques","volume":"2","author":"Xu","year":"2014","journal-title":"Redox Biol."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2015.08.011_bib30","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1007\/s00018-012-1009-2","article-title":"NADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTS","volume":"69","author":"Cifuentes-Pagano","year":"2012","journal-title":"Cell Mol. Life Sci."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2015.08.011_bib31","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1161\/ATVBAHA.112.300031","article-title":"Thrombospondin-1 regulates blood flow via CD47 receptor-mediated activation of NADPH oxidase 1","volume":"32","author":"Csanyi","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2015.08.011_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrd3403","article-title":"Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets","volume":"10","author":"Drummond","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2015.08.011_bib33","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/CIRCULATIONAHA.113.006824","article-title":"Assessment of atherosclerosis in chronic granulomatous disease","volume":"130","author":"Sibley","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.011_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2013.09.019","article-title":"The role of monocytes in angiogenesis and atherosclerosis","volume":"63","author":"Jaipersad","year":"2014","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2015.08.011_bib35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s12265-013-9469-9","article-title":"Macrophages transmit potent proangiogenic effects of oxLDL in\u00a0vitro and in\u00a0vivo involving HIF-1alpha activation: a novel aspect of angiogenesis in atherosclerosis","volume":"6","author":"Hutter","year":"2013","journal-title":"J.\u00a0Cardiovasc. Transl. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.011_bib36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2012.05.003","article-title":"Protection against vascular aging in Nox2-deficient mice: impact on endothelial progenitor cells and reparative neovascularization","volume":"223","author":"Turgeon","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.011_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000079736","article-title":"Vascular endothelial growth factor and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with plaque destabilization via neovascularization","volume":"18","author":"Papalambros","year":"2004","journal-title":"Cerebrovasc. Dis."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.08.011_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.bbamcr.2011.02.009","article-title":"Visfatin exerts angiogenic effects on human umbilical vein endothelial cells through the mTOR signaling pathway","volume":"1813","author":"Park","year":"2011","journal-title":"Biochimica Biophysica Acta"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2015.08.011_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cytogfr.2013.05.006","article-title":"Pre-B cell colony enhancing factor (PBEF), a cytokine with multiple physiological functions","volume":"24","author":"Sun","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2015.08.011_bib40","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1161\/CIRCULATIONAHA.106.665893","article-title":"Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization","volume":"115","author":"Dahl","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2015.08.011_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1570161052773861","article-title":"Macrophage activation in atherosclerosis: pathogenesis and pharmacology of plaque rupture","volume":"3","author":"Boyle","year":"2005","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2015.08.011_bib42","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4162\/nrp.2008.2.2.134","article-title":"Chemokine Lkn-1\/CCL15 enhances matrix metalloproteinase-9 release from human macrophages and macrophage-derived foam cells","volume":"2","author":"Kwon","year":"2008","journal-title":"Nutr. Res. Pract."},{"issue":"11","key":"10.1016\/j.atherosclerosis.2015.08.011_bib43","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1161\/ATVBAHA.114.303086","article-title":"NADPH oxidase deficiency exacerbates angiotensin II-induced abdominal aortic aneurysms in mice","volume":"34","author":"Kigawa","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015300745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T09:50:34Z","timestamp":1537437034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015300745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0021915015300745"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.011","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective inactivation of NADPH oxidase 2 causes regression of vascularization and the size and stability of atherosclerotic plaques","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}